NM_177438.3:c.4206+7_4206+8dupTT

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_177438.3(DICER1):​c.4206+7_4206+8dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0484 in 26,818 control chromosomes in the GnomAD database, including 29 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.048 ( 29 hom., cov: 30)
Exomes 𝑓: 0.018 ( 101 hom. )
Failed GnomAD Quality Control

Consequence

DICER1
NM_177438.3 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.425

Publications

0 publications found
Variant links:
Genes affected
DICER1 (HGNC:17098): (dicer 1, ribonuclease III) This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]
DICER1 Gene-Disease associations (from GenCC):
  • DICER1-related tumor predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pleuropulmonary blastoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • DICER1 syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 14-95099771-C-CAA is Benign according to our data. Variant chr14-95099771-C-CAA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 221129.We mark this variant Benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0589 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DICER1NM_177438.3 linkc.4206+7_4206+8dupTT splice_region_variant, intron_variant Intron 22 of 26 ENST00000343455.8 NP_803187.1 Q9UPY3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DICER1ENST00000343455.8 linkc.4206+8_4206+9insTT splice_region_variant, intron_variant Intron 22 of 26 1 NM_177438.3 ENSP00000343745.3 Q9UPY3-1

Frequencies

GnomAD3 genomes
AF:
0.0482
AC:
1289
AN:
26738
Hom.:
29
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0619
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0344
Gnomad ASJ
AF:
0.0410
Gnomad EAS
AF:
0.0155
Gnomad SAS
AF:
0.0371
Gnomad FIN
AF:
0.00540
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.0394
Gnomad OTH
AF:
0.0461
GnomAD2 exomes
AF:
0.00964
AC:
1645
AN:
170614
AF XY:
0.00887
show subpopulations
Gnomad AFR exome
AF:
0.0358
Gnomad AMR exome
AF:
0.0126
Gnomad ASJ exome
AF:
0.0117
Gnomad EAS exome
AF:
0.00212
Gnomad FIN exome
AF:
0.00414
Gnomad NFE exome
AF:
0.00623
Gnomad OTH exome
AF:
0.0115
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0183
AC:
4990
AN:
272402
Hom.:
101
Cov.:
34
AF XY:
0.0185
AC XY:
2470
AN XY:
133590
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0546
AC:
693
AN:
12700
American (AMR)
AF:
0.0487
AC:
240
AN:
4924
Ashkenazi Jewish (ASJ)
AF:
0.0272
AC:
123
AN:
4516
East Asian (EAS)
AF:
0.0183
AC:
44
AN:
2402
South Asian (SAS)
AF:
0.0266
AC:
381
AN:
14336
European-Finnish (FIN)
AF:
0.00322
AC:
29
AN:
9006
Middle Eastern (MID)
AF:
0.0375
AC:
59
AN:
1574
European-Non Finnish (NFE)
AF:
0.0148
AC:
3128
AN:
211356
Other (OTH)
AF:
0.0253
AC:
293
AN:
11588
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.353
Heterozygous variant carriers
0
241
482
722
963
1204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0484
AC:
1299
AN:
26818
Hom.:
29
Cov.:
30
AF XY:
0.0445
AC XY:
580
AN XY:
13022
show subpopulations
African (AFR)
AF:
0.0624
AC:
862
AN:
13822
American (AMR)
AF:
0.0344
AC:
72
AN:
2092
Ashkenazi Jewish (ASJ)
AF:
0.0410
AC:
22
AN:
536
East Asian (EAS)
AF:
0.0155
AC:
3
AN:
194
South Asian (SAS)
AF:
0.0367
AC:
25
AN:
682
European-Finnish (FIN)
AF:
0.00540
AC:
10
AN:
1852
Middle Eastern (MID)
AF:
0.100
AC:
7
AN:
70
European-Non Finnish (NFE)
AF:
0.0394
AC:
279
AN:
7080
Other (OTH)
AF:
0.0452
AC:
19
AN:
420
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
57
114
172
229
286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00806
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:3
Jul 01, 2019
Foulkes Cancer Genetics LDI, Lady Davis Institute for Medical Research
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

ACMG criteria met: None -

Sep 06, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DICER1-related tumor predisposition Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 07, 2021
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pleuropulmonary blastoma Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555368535; hg19: chr14-95566108; COSMIC: COSV100601699; COSMIC: COSV100601699; API